Related references
Note: Only part of the references are listed.Oligodendroglial neoplasms with ganglioglioma-like maturation: a diagnostic pitfall
Arie Perry et al.
ACTA NEUROPATHOLOGICA (2010)
Expression of oligodendroglial and astrocytic lineage markers in diffuse gliomas: Use of YKL-40, ApoE, ASCL1, and NKX2-2
Audrey Rousseau et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas
KL Ligon et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas
Y Okamoto et al.
ACTA NEUROPATHOLOGICA (2004)
Supratentorial gangliogliomas:: Histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years
C Luyken et al.
CANCER (2004)
Molecular pathogenesis of oligodendroglial tumors
JWM Jeuken et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
Oligodendroglioma: Toward molecular definitions in diagnostic neuro-oncology
G Reifenberger et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
The bHLH transcription factor Olig2 promotes oligodendrocyte differentiation in collaboration with Nkx2.2
Q Zhou et al.
NEURON (2001)
Oligodendroglial ganglioglioma with anaplastic features arising from the thalamus
MD Johnson et al.
PEDIATRIC NEUROSURGERY (2001)
Share Paper
